Nukleus Office Solutions' SME IPO, aiming to raise Rs 32 crore, saw 87% subscription by its final bidding day. The retail ...

Cloud computing company CoreWeave is mulling filing publicly for an IPO in the U.S. within a week, Bloomberg’s Bailey ...

After an improving IPO market in 2024, the IPO market may fare well in 2025, especially with some hot names on deck. That ...

International Gemmological Institute India Ltd (IGIL), a newly-listed company, is set to pay an interim dividend to its ...

NSDL, India's largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...

This will be Boat's second attempt to go public after an abortive attempt in 2022. According to sources, the company is ...

The company's board approved the opening of the issue on February 25 for the QIP of equity shares with a face value of Rs 2 ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Investing in ThoughtSpot’s IPO might be a good move to add to your portfolio, It has beating out competitors other analytics ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

Basel Medical Group (NASDAQ:BMGL) shares were up 4% in late afternoon trading Tuesday following a $9M U.S. initial public ...

In bull and bear markets, investors need rules to stay both profitable and protected. Here are seven lessons to get started.